These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 32562528)

  • 1. Multi-objective Genetic Algorithm for De Novo Drug Design (MoGADdrug).
    Devi RV; Sathya SS; Coumar MS
    Curr Comput Aided Drug Des; 2021; 17(3):445-457. PubMed ID: 32562528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FOG: Fragment Optimized Growth algorithm for the de novo generation of molecules occupying druglike chemical space.
    Kutchukian PS; Lou D; Shakhnovich EI
    J Chem Inf Model; 2009 Jul; 49(7):1630-42. PubMed ID: 19527020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [In Silico Drug Design Using an Evolutionary Algorithm and Compound Database].
    Kawai K; Takahashi Y
    Yakugaku Zasshi; 2016; 136(1):107-12. PubMed ID: 26725677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancing reaction-based de novo design using a multi-label reaction class recommender.
    Ghiandoni GM; Bodkin MJ; Chen B; Hristozov D; Wallace JEA; Webster J; Gillet VJ
    J Comput Aided Mol Des; 2020 Jul; 34(7):783-803. PubMed ID: 32112286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In silico fragment-based drug discovery: setup and validation of a fragment-to-lead computational protocol using S4MPLE.
    Hoffer L; Renaud JP; Horvath D
    J Chem Inf Model; 2013 Apr; 53(4):836-51. PubMed ID: 23537132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemical-Space-Based de Novo Design Method To Generate Drug-Like Molecules.
    Takeda S; Kaneko H; Funatsu K
    J Chem Inf Model; 2016 Oct; 56(10):1885-1893. PubMed ID: 27632418
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Domenico A; Nicola G; Daniela T; Fulvio C; Nicola A; Orazio N
    J Chem Inf Model; 2020 Oct; 60(10):4582-4593. PubMed ID: 32845150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Pareto Algorithm for Efficient De Novo Design of Multi-functional Molecules.
    Daeyaert F; Deem MW
    Mol Inform; 2017 Jan; 36(1-2):. PubMed ID: 28124835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LEADD: Lamarckian evolutionary algorithm for de novo drug design.
    Kerstjens A; De Winter H
    J Cheminform; 2022 Jan; 14(1):3. PubMed ID: 35033209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MoleGear: A Java-Based Platform for Evolutionary De Novo Molecular Design.
    Chu Y; He X
    Molecules; 2019 Apr; 24(7):. PubMed ID: 30979097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 'Metabolite-likeness' as a criterion in the design and selection of pharmaceutical drug libraries.
    Dobson PD; Patel Y; Kell DB
    Drug Discov Today; 2009 Jan; 14(1-2):31-40. PubMed ID: 19049901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design of novel ROCK inhibitors using fragment-based de novo drug design approach.
    Arya H; Coumar MS
    J Mol Model; 2020 Aug; 26(9):249. PubMed ID: 32829478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A genetic algorithm for the automated generation of small organic molecules: drug design using an evolutionary algorithm.
    Douguet D; Thoreau E; Grassy G
    J Comput Aided Mol Des; 2000 Jul; 14(5):449-66. PubMed ID: 10896317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. De novo design of potential RecA inhibitors using multi objective optimization.
    Sengupta S; Bandyopadhyay S
    IEEE/ACM Trans Comput Biol Bioinform; 2012; 9(4):1139-54. PubMed ID: 22392725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. De novo design - hop(p)ing against hope.
    Schneider G
    Drug Discov Today Technol; 2013 Dec; 10(4):e453-60. PubMed ID: 24451634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. De novo design of drug-like molecules by a fragment-based molecular evolutionary approach.
    Kawai K; Nagata N; Takahashi Y
    J Chem Inf Model; 2014 Jan; 54(1):49-56. PubMed ID: 24372539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AutoGrow: a novel algorithm for protein inhibitor design.
    Durrant JD; Amaro RE; McCammon JA
    Chem Biol Drug Des; 2009 Feb; 73(2):168-78. PubMed ID: 19207419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multi-objective optimization methods in drug design.
    Nicolaou CA; Brown N
    Drug Discov Today Technol; 2013 Sep; 10(3):e427-35. PubMed ID: 24050140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fragment-Based Drug Design of Selective HDAC6 Inhibitors.
    Ruzic D; Djokovic N; Nikolic K
    Methods Mol Biol; 2021; 2266():155-170. PubMed ID: 33759126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitatively integrating molecular structure and bioactivity profile evidence into drug-target relationship analysis.
    Xu T; Zhu R; Liu Q; Cao Z
    BMC Bioinformatics; 2012 May; 13():75. PubMed ID: 22559876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.